<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2007-7459</journal-id>
<journal-title><![CDATA[Horizonte sanitario]]></journal-title>
<abbrev-journal-title><![CDATA[Horiz. sanitario]]></abbrev-journal-title>
<issn>2007-7459</issn>
<publisher>
<publisher-name><![CDATA[Universidad Juárez Autónoma de Tabasco, División Académica de Ciencias de la Salud]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2007-74592021000100049</article-id>
<article-id pub-id-type="doi">10.19136/hs.a20n1.3820</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Reacciones adversas a medicamentos de baja frecuencia en Matanzas, Cuba 2014-2018]]></article-title>
<article-title xml:lang="en"><![CDATA[Adverse reactions to low frequency drugs in Matanzas, Cuba 2014-2018]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Santos Muñoz]]></surname>
<given-names><![CDATA[Leidy]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García Milián]]></surname>
<given-names><![CDATA[Ana Julia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sánchez Pérez]]></surname>
<given-names><![CDATA[Diriana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Laguardia Aldama]]></surname>
<given-names><![CDATA[Dania]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas de Matanzas  ]]></institution>
<addr-line><![CDATA[Matanzas ]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Corporación de Salud del Maresma y la Selva  ]]></institution>
<addr-line><![CDATA[Cataluña ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad de Ciencias Médicas de Matanzas  ]]></institution>
<addr-line><![CDATA[Matanzas ]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad de Ciencias Médicas de Matanzas  ]]></institution>
<addr-line><![CDATA[Matanzas ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2021</year>
</pub-date>
<volume>20</volume>
<numero>1</numero>
<fpage>49</fpage>
<lpage>56</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2007-74592021000100049&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2007-74592021000100049&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2007-74592021000100049&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo:  Caracterizar las reacciones adversas medicamentosas de baja frecuencia de aparición, recibidas en la Unidad Coordinadora Provincial de Farmacovigilancia, del 2014 al 2018.  Materiales y Método:  Estudio observacional, descriptivo, transversal, de serie de casos en Farmacovigilancia, a partir de la notificación espontánea de sospechas de reacciones adversas en el quinquenio 2014 - 2018, en Matanzas. La información se obtuvo de la base de datos provincial de farmacovigilancia. Se describen las reacciones adversas de baja frecuencia en cuanto a sexo, edad, tipo de efecto adverso, intensidad e imputabilidad.  Resultados:  Se evaluaron un total de 3,407 reacciones adversas por medicamentos de baja frecuencia. Prevalecieron las clasificadas como ocasionales con 1,741 notificaciones (51.1%). El sexo femenino y los adultos fueron los más reportados. Se afectó en mayor cuantía la piel y anejos; los grupos farmacológicos más reportados fueron los analgésicos, seguido de los antimicrobianos, siendo los fármacos con mayor implicación la dipirona (7.1%) y el ibuprofeno (5.8 %). Predominaron las reacciones adversas por medicamentos de baja frecuencia moderadas (93.3%) y las probables (72.2%) según imputabilidad.  Conclusiones:  En Matanzas, en el período 2014-2018 se reportaron reacciones adversas a medicamentos de baja frecuencia en su mayoría ocasionales y probables en piel y anejos, producida por analgésicos y antimicrobianos en el sexo femenino y adultos, de moderada intensidad.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective.  To characterize the adverse drug reactions of low frequency of appearance, received in the Provincial Coordinating Unit of Pharmacovigilance from 2014 to 2018.  Method:  Observational, descriptive, cross-sectional study of a series of cases in Pharmacovigilance, based on the spontaneous notification of suspected adverse reactions from 2014 to 2018, in Matanzas. The necessary information was obtained from the pharmacovigilance provincial database. Low-frequency adverse reactions are described in terms of sex, age, type of adverse effect, intensity and imputability, among other variables.  Results:  There were evaluated a total of 3407 adverse reactions due to low frequency medications. Those classified as occasional prevailed with 1,741 notifications (51.1%). Female sex and adults were the most reported. Analgesics followed by antimicrobials, and the drugs with the greatest involvement were dipyrone (7.1%) and ibuprofen (5.8%). Adverse reactions to moderate low frequency drugs (93.3%) and probable (72.2%) prevailed according to imputability.  Conclusions:  adverse reactions to low-frequency medications were reported in Matanzas, in the period 2014-2018, mostly occasional and probable in skin and appendages, produced by analgesics and antimicrobials in females and adults, of moderate intensity.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Farmacovigilancia]]></kwd>
<kwd lng="es"><![CDATA[Reacciones adversas]]></kwd>
<kwd lng="es"><![CDATA[Reacciones adversas de baja frecuencia]]></kwd>
<kwd lng="en"><![CDATA[Pharmacovigilance]]></kwd>
<kwd lng="en"><![CDATA[Adverse reactions]]></kwd>
<kwd lng="en"><![CDATA[Low frequency adverse reactions]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez-Ricart]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Gea Rodríguez]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Gil Máñez]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-Feliu]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Roca Montañana]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Pascual Martínez]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Implicación del farmacéutico de hospital en la Farmacovigilancia]]></article-title>
<source><![CDATA[El Farmacéutico Hospitales.]]></source>
<year>2017</year>
<page-range>10-4</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kaeding]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Schmälter]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Klika]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Timely and Correct Transposition of Pharmacovigilance across Member States]]></article-title>
<source><![CDATA[Pharmacovigilance in the European Union Duisburg: Springer]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goodman]]></surname>
</name>
<name>
<surname><![CDATA[Gilman&#8217;s.]]></surname>
</name>
</person-group>
<source><![CDATA[The Pharmacological Basis of Therapeutics. Capítulo 1 &#8220;Invención de fármacos y la industria farmacéutica&#8221;]]></source>
<year>2018</year>
<edition>7.13</edition>
<publisher-name><![CDATA[Mc Graw Hill Medical]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chávez-Lemus]]></surname>
<given-names><![CDATA[FA.]]></given-names>
</name>
<name>
<surname><![CDATA[Reynoso-Von Drateln]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Martínez]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de las farmacodermias en pacientes hospitalizados en el Servicio de Dermatología de la UMAE del Centro Médico Nacional de Occidente Periodo 2004-2012]]></article-title>
<source><![CDATA[Revista Mexicana de Dermatología]]></source>
<year>2014</year>
<volume>58</volume>
<page-range>339-45</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maza Larrea]]></surname>
<given-names><![CDATA[JA.]]></given-names>
</name>
<name>
<surname><![CDATA[Aguilar Anguiano]]></surname>
<given-names><![CDATA[LM.]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza Betancourt]]></surname>
<given-names><![CDATA[JA.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Farmacovigilancia: un paso importante en la seguridad del paciente]]></article-title>
<source><![CDATA[Revista Sanidad Militar Mexicana]]></source>
<year>2018</year>
<volume>72</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>47-53</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6.</label><nlm-citation citation-type="">
<collab>World Health Organization</collab>
<source><![CDATA[Global Patient Safety Challenge on Medication Safety: Medication without harm [Internet] WHO: World Health Organization, WHO/HIS/ SDS/2017.6;]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B7">
<label>7.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lundin]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Postive trends for VigiBase: 12 million reports &amp; counting.]]></article-title>
<source><![CDATA[Uppsala Reports-Covering the world of pharmacovigilance-]]></source>
<year>2016</year>
<volume>72</volume>
<page-range>14-5</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pedersen]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Sara-Lisa]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[VigiBase-global reporting trends]]></article-title>
<source><![CDATA[Uppsala Reports-Covering the world of pharmacovigilance-]]></source>
<year>2011</year>
<volume>55</volume>
<page-range>6-7</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Naranjo]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Usoa]]></surname>
<given-names><![CDATA[EB]]></given-names>
</name>
</person-group>
<source><![CDATA[Reacciones adversas a medicamentos. En: Métodos de farmacovigilancia clínica]]></source>
<year>1992</year>
<page-range>330-50</page-range><publisher-name><![CDATA[IRIS PAHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García Milián]]></surname>
<given-names><![CDATA[AJ.]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso Carbonell]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[López Puig]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Investigación sobre consumo de medicamentos. Experiencia cubana]]></source>
<year>2013</year>
<page-range>120</page-range><publisher-loc><![CDATA[La Habana, Cuba, ]]></publisher-loc>
<publisher-name><![CDATA[ECIMED. OPS/ENSAP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santos Muñoz]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez López]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Alfonso Orta]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización de las reacciones adversas medicamentosas de baja frecuencia de aparición]]></article-title>
<source><![CDATA[Revista Cubana de Salud Pública]]></source>
<year>2018</year>
<volume>44</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>12</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12.</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jiménez López]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso Orta]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
</person-group>
<source><![CDATA[Normas y procedimientos de trabajo del Sistema Cubano de Farmacovigilancia. Ministerio de Salud Pública (MINSAP), Dirección Nacional de Medicamentos y Equipos Médicos]]></source>
<year>2015</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B13">
<label>13.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ríos-Quintana]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Estrada-Hernández]]></surname>
<given-names><![CDATA[LO.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Descripción y cuantificación de riesgos atribuidos a analgésicos antiinflamatorios no esteroides no selectivos consumidos por la población mexicana]]></article-title>
<source><![CDATA[Medicina Interna de México]]></source>
<year>2018</year>
<volume>34</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>173-87</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López Pfister]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Virgam]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Aguzzi]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[De Leonardi]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[De Leonardi]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Farmacovigilancia: hacia una mayor seguridad en el uso de medicamentos]]></article-title>
<source><![CDATA[Facultad de Ciencias Médicas]]></source>
<year>2018</year>
<page-range>699</page-range><publisher-loc><![CDATA[Universidad Nacional de Córdoba ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B15">
<label>15.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jiménez López]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[García Fariñas]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Gálvez González]]></surname>
<given-names><![CDATA[AM.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medicamentos notificados como productores de reacciones adversas graves en Cuba en un período de diez años]]></article-title>
<source><![CDATA[Revista Cubana de Salud Pública]]></source>
<year>2014</year>
<volume>40</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>263-75</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santos Muñoz]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Identificación de señales en reacciones adversas de baja frecuencia. Cuba 2004-2008.]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Ciudad de La Habana ]]></publisher-loc>
<publisher-name><![CDATA[ENSAP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Machado-Alba]]></surname>
<given-names><![CDATA[JE.]]></given-names>
</name>
<name>
<surname><![CDATA[Londoño-Builes]]></surname>
<given-names><![CDATA[MJ.]]></given-names>
</name>
<name>
<surname><![CDATA[Echeverri- Cataño]]></surname>
<given-names><![CDATA[LF.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reacciones adversas a medicamentos en una población colombiana, 2007-2013 : análisis de bases de datos]]></article-title>
<source><![CDATA[Biomédica Revista del Instituto Nacional de Salud]]></source>
<year>2016</year>
<volume>36</volume>
<page-range>59-66</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Furones Mourelle]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Druyet Castillo]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[López Aguilera]]></surname>
<given-names><![CDATA[AF.]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz Barrios]]></surname>
<given-names><![CDATA[MA.]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez López]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reacciones adversas no descritas en embarazadas de Cuba.]]></article-title>
<source><![CDATA[Rev. Cubana de Farmacia]]></source>
<year>2015</year>
<volume>49</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>291-303</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De las Salas]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz-Agudelo]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reacciones adversas a medicamentos en neonatos hospitalizados en unidades de cuidado intensivo neonatal en Barranquilla, Colombia]]></article-title>
<source><![CDATA[Biomédica Revista del Instituto Nacional de Salud]]></source>
<year>2017</year>
<volume>37</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>33-42</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tanguila Andi]]></surname>
<given-names><![CDATA[O.L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Elaboración de un plan piloto para el desarrollo del sistema de Farmacovigilancia dirigido a pacientes de hospitalización en el área de medicina interna, del hospital José María Velasco Ibarra de Tena]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Ecuador ]]></publisher-loc>
<publisher-name><![CDATA[Escuela Superior Politécnica de Chimborazo;]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B21">
<label>21.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García Milian]]></surname>
<given-names><![CDATA[AJ.]]></given-names>
</name>
<name>
<surname><![CDATA[González del Sol]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Carbonell Liuba]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Reid Armenteros]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[López Puig]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez Martínez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[El consumo de medicamento y su medició]]></source>
<year>2015</year>
<edition>2ª</edition>
<page-range>106</page-range><publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Virtual Health Library]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
